A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease (AMBAR)
This study is currently recruiting participants.
Verified November 2012 by Grifols Biologicals Inc.
Sponsor:
Instituto Grifols, S.A.
Collaborator:
Grifols Biologicals Inc.
Information provided by (Responsible Party):
Grifols Biologicals Inc. ( Instituto Grifols, S.A. )
ClinicalTrials.gov Identifier:
NCT01561053
First received: March 16, 2012
Last updated: November 26, 2012
Last verified: November 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | December 2014 |
| Estimated Primary Completion Date: | December 2014 (Final data collection date for primary outcome measure) |